These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 15486260

  • 1. Medicine. Microbicide shuts the door on HIV.
    Cohen J.
    Science; 2004 Oct 15; 306(5695):387. PubMed ID: 15486260
    [No Abstract] [Full Text] [Related]

  • 2. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
    Lederman MM, Veazey RS, Offord R, Mosier DE, Dufour J, Mefford M, Piatak M, Lifson JD, Salkowitz JR, Rodriguez B, Blauvelt A, Hartley O.
    Science; 2004 Oct 15; 306(5695):485-7. PubMed ID: 15486300
    [Abstract] [Full Text] [Related]

  • 3. Topical microbicides become topical.
    Moore JP.
    N Engl J Med; 2005 Jan 20; 352(3):298-300. PubMed ID: 15659734
    [No Abstract] [Full Text] [Related]

  • 4. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
    Veazey RS, Klasse PJ, Schader SM, Hu Q, Ketas TJ, Lu M, Marx PA, Dufour J, Colonno RJ, Shattock RJ, Springer MS, Moore JP.
    Nature; 2005 Nov 03; 438(7064):99-102. PubMed ID: 16258536
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor density.
    Willey S, Peters PJ, Sullivan WM, Dorr P, Perros M, Clapham PR.
    Antiviral Res; 2005 Nov 03; 68(2):96-108. PubMed ID: 16157392
    [Abstract] [Full Text] [Related]

  • 6. Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor.
    Veazey RS, Springer MS, Marx PA, Dufour J, Klasse PJ, Moore JP.
    Nat Med; 2005 Dec 03; 11(12):1293-4. PubMed ID: 16273102
    [Abstract] [Full Text] [Related]

  • 7. Repetitive exposures with simian/human immunodeficiency viruses: strategy to study HIV pre-clinical interventions in non-human primates.
    Kim CN, Adams DR, Bashirian S, Butera S, Folks TM, Otten RA.
    J Med Primatol; 2006 Aug 03; 35(4-5):210-6. PubMed ID: 16872284
    [Abstract] [Full Text] [Related]

  • 8. Repeated intravaginal inoculation with cell-associated simian immunodeficiency virus results in persistent infection of nonhuman primates.
    Kaizu M, Weiler AM, Weisgrau KL, Vielhuber KA, May G, Piaskowski SM, Furlott J, Maness NJ, Friedrich TC, Loffredo JT, Usborne A, Rakasz EG.
    J Infect Dis; 2006 Oct 01; 194(7):912-6. PubMed ID: 16960778
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of -2 RANTES vaginal microbicide formulations in a nonhuman primate simian/human immunodeficiency virus (SHIV) challenge model.
    Kish-Catalone T, Pal R, Parrish J, Rose N, Hocker L, Hudacik L, Reitz M, Gallo R, Devico A.
    AIDS Res Hum Retroviruses; 2007 Jan 01; 23(1):33-42. PubMed ID: 17263630
    [Abstract] [Full Text] [Related]

  • 10. Microbicides and other topical strategies to prevent vaginal transmission of HIV.
    Lederman MM, Offord RE, Hartley O.
    Nat Rev Immunol; 2006 May 01; 6(5):371-82. PubMed ID: 16639430
    [Abstract] [Full Text] [Related]

  • 11. Can microbicides prevent medical transmission in MSM? Vaginal microbicides will be used rectally.
    AIDS Alert; 2010 Dec 01; 25(12):135-6. PubMed ID: 21328809
    [No Abstract] [Full Text] [Related]

  • 12. The future of HIV prevention: prospects for an effective anti-HIV microbicide.
    Nuttall J, Romano J, Douville K, Galbreath C, Nel A, Heyward W, Mitchnick M, Walker S, Rosenberg Z.
    Infect Dis Clin North Am; 2007 Mar 01; 21(1):219-39, x. PubMed ID: 17502237
    [Abstract] [Full Text] [Related]

  • 13. Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor.
    Veazey RS, Ketas TJ, Dufour J, Moroney-Rasmussen T, Green LC, Klasse PJ, Moore JP.
    J Infect Dis; 2010 Sep 01; 202(5):739-44. PubMed ID: 20629537
    [Abstract] [Full Text] [Related]

  • 14. HIV vaccination dilemma.
    Sabin AB.
    Nature; 1993 Mar 18; 362(6417):212. PubMed ID: 8318105
    [No Abstract] [Full Text] [Related]

  • 15. [Postexposure HIV-prophylaxis in the eyes].
    Goebel FD.
    Dtsch Med Wochenschr; 2001 Nov 30; 126(48):1379. PubMed ID: 11780177
    [No Abstract] [Full Text] [Related]

  • 16. Ongoing microbicide studies may lead to more options. Daily doses and a vaginal ring are being tried.
    AIDS Alert; 2010 Dec 30; 25(12):136-7. PubMed ID: 21328810
    [No Abstract] [Full Text] [Related]

  • 17. Microbicide offers no protection against HIV infection.
    Roehr B.
    BMJ; 2009 Dec 18; 339():b5538. PubMed ID: 20022912
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of vaginal transmission of a simian human immunodeficiency virus (SHIV) encoding the reverse transcriptase gene from HIV-1 in Chinese rhesus macaques.
    Pal R, Nuttall J, Galmin L, Weiss D, Chung HK, Romano J.
    Virology; 2009 Mar 30; 386(1):102-8. PubMed ID: 19195672
    [Abstract] [Full Text] [Related]

  • 19. Advances in microbicide vaginal rings.
    Malcolm RK, Edwards KL, Kiser P, Romano J, Smith TJ.
    Antiviral Res; 2010 Dec 30; 88 Suppl 1():S30-9. PubMed ID: 21109066
    [Abstract] [Full Text] [Related]

  • 20. Public health. Regulatory challenges in microbicide development.
    Coplan PM, Mitchnick M, Rosenberg ZF.
    Science; 2004 Jun 25; 304(5679):1911-2. PubMed ID: 15218130
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.